Drug Name:
MAALOX MAX STR OTC
Generic Name and Formulations:
Aluminum hydroxide 500mg, magnesium hydroxide 450mg, simethicone 40mg; per 5mL; liq; mint or cherry flavor.
Company:
Novartis Consumer Health
Therapeutic Use:
Indications for MAALOX MAX STR:
Heartburn, acid indigestion, sour stomach, upset stomach.
Adult:
10–20mL 4 times daily; max 60mL/day.
Children:
Not recommended.
Warnings/Precautions:
Impaired renal function (aluminum/magnesium forms).
See Also:
MAALOX THERAPEUTIC CONCENTRATE
Pharmacological Class:
Antacid + antiflatulent.
Interactions:
Reduces absorption of tetracyclines, possibly other drugs.
How Supplied:
Susp (mint)—5oz, 12oz, 26oz; Susp (lemon, cherry)—12oz, 26oz; Therapeutic Conc—12oz; Tabs (berry, wintergreen)—45, 85; Tabs (lemon)—30, 45, 85; Max Str tabs—35, 65; Max Str susp (lemon)—5oz, 12oz, 26oz; Max Str susp (mint, cherry)—12oz, 26oz
Sign Up for Free e-newsletters
ONA Articles
- Real World Results May Not Mirror Clinical Study Outcomes in Multiple Myeloma
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer
- Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Health Domains May Mediate Psychological Risk in Survivors of Childhood Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |